Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Yizhang Zhou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109517165. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 1 paper

Papers 4

  1. SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC. Co-author DOI 10.7150/ijbs.64752↗
  2. Delta HU is a potential marker to predict chemotherapy response for unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.02.016↗
  3. OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.698302↗
  4. KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target. Last author DOI 10.21037/atm-20-1970↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Song Gao · 2 shared papers, 2021–2022 · strength 0.28
  2. Jihui Hao · 2 shared papers, 2021–2022 · strength 0.28
  3. Xiaofan Guo · 2 shared papers, 2020–2021 · strength 0.26
  4. Chuntao Gao · 2 shared papers, 2020–2021 · strength 0.26
  5. Shengyu Yang · 1 shared paper, 2022 · strength 0.15
  6. Shuai Yuan · 1 shared paper, 2022 · strength 0.15
  7. Mingxiao Lang · 1 shared paper, 2022 · strength 0.15
  8. Zhe Liu · 1 shared paper, 2022 · strength 0.15
  9. Shengnan Li · 1 shared paper, 2020 · strength 0.13
  10. Shuai Yuan · 1 shared paper, 2021 · strength 0.13
  11. He Ren · 1 shared paper, 2021 · strength 0.13
  12. Yang Liu · 1 shared paper, 2021 · strength 0.12
  13. Jinsheng Ding · 1 shared paper, 2021 · strength 0.12
  14. Yongjie Xie · 1 shared paper, 2021 · strength 0.12
  15. Huizhi Sun · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.